S105: IN VIVO PDX CRISPR/CAS9 SCREENS REVEAL MUTUAL THERAPEUTIC TARGETS TO OVERCOME HETEROGENEOUS ACQUIRED CHEMO-RESISTANCE

• A.-K. Wirth,
• L. Wange,
• S. Vosberg,
• A. K. Jayavelu,
• W Enard,
• T Herold,
• I Jeremias

Affiliations

A.-K. Wirth

1 Apoptosis in Hematopoietic stem cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich

L. Wange

2 Anthropology and Human Genomics, Faculty of Biology, Ludwig Maximilian University (LMU), Martinsried, Germany

S. Vosberg

3 Clinical Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

A. K. Jayavelu

4 Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried

W Enard

2 Anthropology and Human Genomics, Faculty of Biology, Ludwig Maximilian University (LMU), Martinsried, Germany

T Herold

5 Department of Medicine III, and Laboratory for Leukemia Diagnostics, Ludwig Maximilian University (LMU), Munich, Germany

I Jeremias

1 Apoptosis in Hematopoietic stem cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich